JP MORGAN/CALL/BOSTON SCIENTIFIC/60/0.1/20.06.25 | Market Closed - Börse Stuttgart 01:30:26 28/06/2024 pm IST | ||
| 2.2 EUR | -0.90% |
|
| Current month | +5.77% | ||
| 1 month | +0.92% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 2.2 | -0.90% |
| 27/24/27 | 2.22 | +0.45% |
| 26/24/26 | 2.21 | +0.45% |
| 25/24/25 | 2.2 | -3.08% |
| 24/24/24 | 2.27 | +1.34% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 01:30 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JB7GT8 |
| ISIN | DE000JB7GT81 |
| Date issued | 06/12/2023 |
| Strike | 60 $ |
| Maturity | 20/06/2025 (355 Days) |
| Parity | 10 : 1 |
| Emission price | 0.6 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.31 € |
|---|---|
| Lowest since issue | 0.9 € |
| Spread | 0.07 € |
| Spread % | 3.10% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
77.01
USD
Average target price
82.35
USD
Spread / Average Target
+6.94%
- Stock Market
- Warrants
- Warrant
